Cocrystal Pharma, Inc. · NASDAQ:COCP
Phillip Frost, M.D. reported a 17.80% stake in Cocrystal Pharma, Inc. (Schedule 13D/A)
Event Oct 28, 2025 · Filed Oct 30, 2025
Phillip Frost, M.D. reported a 17.80% stake in Cocrystal Pharma, Inc., 2,462,012 shares, with active intent on Oct 28, 2025. Filed Oct 30, 2025 (Schedule 13D/A).
- Stake
- 17.80%
- Shares
- 2,462,012
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Phillip Frost, M.D. | 17.80% | 2,462,012 |
| Frost Gamma Investments Trust | 17.40% | 2,398,977 |
Source
Related
- Cocrystal Pharma, Inc.
- Frost Gamma Investments Trust
- Cocrystal Pharma, Inc. shareholders
- Schedule 13D/A · Frost Gamma Investments Trust · Aug 7, 2026
- Schedule 13D/A · Frost Gamma Investments Trust · Oct 2, 2025
- Schedule 13D · Opko Health, Inc. · Aug 7, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 6, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 5, 2026